Royalty Pharma Plc (RPRX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$39.93B
EV to revenue ratio (TTM)
14.42
EV to ebitda
24.34
Financial Performance
Revenue (TTM)
$2.62B
Gross profit (TTM)
$2.61B
EBITDA
$1.69B
Profitability
Operating margin (TTM)
81.30%
Profit margin
25.70%
Return on assets (TTM)
5.43%
Return on equity (TTM)
12.10%
Per Share Metrics
Revenue per share (TTM)
$5.96
EPS
$1.53
Diluted EPS (TTM)
$1.53
Book value
$15.34
Dividend per share
$0.93
Dividend yield
1.35%
Valuation Multiples
P/E ratio
45.39
Trailing P/E
45.39
Forward P/E
34.01
PEG ratio
2.09
Price to sales ratio (TTM)
15.26
Price to book ratio (TTM)
4.48
Growth
Quarterly earnings growth (YoY)
13.30%
Quarterly revenue growth (YoY)
-50.80%
Analyst Sentiment
Strong buy
2
Buy
5
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.36